Timber Pharmaceuticals LLC insider trades: BioPharmX (BPMX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timber Pharmaceuticals LLC reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 10, 2020 | BPMX | ↓ Sell | 55,008 | $0.01 | $550 | Direct | Feb 12, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Timber Pharmaceuticals LLC's insider trades
Timber Pharmaceuticals LLC is a 10% owner of BioPharmX (BPMX). Since Feb 10, 2020, it has reported no open-market purchases and 1 sale worth $550 on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BPMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.